GeneCentric Therapeutics has earned an initial $8m in a Series C funding round, marking a step towards the launch and ...

My mother has been diagnosed with breast cancer, and I’m helping with her medical appointments. Her oncologist says she needs ...

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...

Navigational bronchoscopy was noninferior to CT-guided biopsy when assessing diagnostic accuracy in patients with lung ...

Diffusion basis spectrum imaging combined with AI enhances diagnostic accuracy for prostate cancer A study published in the ...

Durham-based GeneCentric Therapeutics, a cancer diagnostics company, has closed on an $8 million round of venture capital to launch and commercialize a novel liquid biopsy platform for guiding ...

Despite the absence of pain signals, post-operative opioids control tachycardia and hypertension, highlighting the unique challenges in pain-insensitive individuals.

Researchers from the UAB have shown that sex hormones accumulate in the skin of sharks. This finding opens a new way for the ...

The global breast biopsy market is anticipated to grow at a steady CAGR of 5.5% during the forecast period 2020-2026, according to a report by Gen Consulting Company.